COMPASS Pathways: Institutional Pressure Amid $43M Market Cap Decline, What’s Next For This Psychedelics Co?
COMPASS Pathways (NASDAQ:CMPS), a key player in the psychedelics industry, recently experienced a $43 million drop in market capitalization, reducing its value to $302 million. As Simply Wall St. reported, this decline has placed institutional investors, who own 30% of the company’s shares, under increasing pressure to act. The stock has already faced a 32% loss over the past year, raising concerns about its future trajectory.
Institutional Ownership And Its Implications
Institutional investors, often referred to as “smart money,” hold the largest stake in COMPASS Pathways. These entities, which include hedge funds owning 13%, are known for their active investment strategies and significant influence on stock prices. A …